Patent directory · USPTO A61K / A61P
Patents matching “Takeda Pharmaceutical Company Limited”
1,022 pharma patents match "Takeda Pharmaceutical Company Limited" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,022 pharmaceutical patents matching "Takeda Pharmaceutical Company Limited" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 8642648
Orally dispersible tablet
granted -
US 8642649
Orally dispersible tablet
granted -
US 8642539
Method for treating a disease characterized by reduced appetite
granted -
US 8637079
Solid preparation comprising alogliptin and pioglitazone
granted -
US 8637077
Sustained-release preparation
granted -
US 8632808
Taste-masking solid preparation of pioglitazone
granted -
US 8623405
Finely divided composition containing poorly water soluble substance
granted -
US 8618290
HSP90 inhibitors
granted -
US 8614208
Fused heterocyclic ring derivative and use thereof
granted -
US 8609871
Process for production of optically active amine derivatives
granted -
US 8598226
Fused cyclic compounds
granted -
US 8592597
Pyrrole compounds
granted -
US 8592598
Method of producing a crystal of an imidazole compound
granted -
US 8592454
Nitrogen-containing heterocyclic compound and use of same
granted -
US 8592452
Cyclic amine compound
granted -
US 8592379
Metastin derivative and use thereof
granted -
US 8592431
Fused ring compound and use thereof
granted -
US 8586762
Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same
granted -
US 8586571
Heterocyclic compound
granted -
US 8575167
Spiro compounds having stearoyl-CoA desaturase action
granted -
US 8575154
Heterocyclic compound and use thereof
granted -
US 8563575
Fused heterocyclic compounds
granted -
US 8557805
Fused ring compound and use thereof
granted -
US 8552198
Benzimidazole compound crystal
granted